Lipiduce 160 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Fenofibrate

Indications/Uses

To reduce LDL cholesterol, total cholesterol, triglycerides, apolipoprotein B & increase HDL cholesterol, in the management of hyperlipidemias including type IIa, type IIb, type III, type IV & type V hyperlipoproteinemias.

Click to view Lipiduce 160 detailed prescribing information

Dosage/Direction for Use

Adult Hypercholesterolemia, primary hypercholesterolemia or mixed dyslipidemia (Fredrickson type 2a, 2b) 160 mg daily. Max: 160 mg/day. Hypertriglyceridemia, Fredrickson types 4 & 5 hyperlipidemia Adjunct to diet: Initially 50-160 mg once daily, adjust dose after repeated lipid tests at 4-8 wk intervals. Max: 160 mg orally daily.

Click to view Lipiduce 160 detailed prescribing information

Overdosage

View Lipiduce 160 overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Gallbladder disease, active liver disease. Severe renal dysfunction. Lactation.

Click to view Lipiduce 160 detailed prescribing information

Special Precautions

Concomitant therapy w/ HMG-CoA reductase inhibitors (eg, lovostatin, pravastatin, simvastatin) or fenofibric acid derivatives (eg, gemfibrozil) should be avoided, concomitant therapy w/ anticoagulants, cholelithiasis, diabetic patients, hypothyroidism, hypersensitivity reactions, myopathies, pancreatitis, renal dysfunction, serum transaminases (AST & ALT) increases of >3 times the upper limit of normal. Childn. Elderly.

Click to view Lipiduce 160 detailed prescribing information

Adverse Reactions

Rash, diarrhea, flatulence, nausea & vomiting, myalgia, rhinitis.

Click to view Lipiduce 160 detailed prescribing information

Drug Interactions

Acenocoumarol, anisindione, atorvastatin, cerivastatin, dicumarol, fluvastatin, lovastatin, phenindione, phenprocoumon, pravastatin, rosuvastatin, simvastatin, warfarin, colestipol, ezetimibe, glimepiride.

Storage

View Lipiduce 160 storage conditions for details to ensure optimal shelf-life.

Description

View Lipiduce 160 description for details of the chemical structure and excipients (inactive components).

Action

View Lipiduce 160 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AB05 - fenofibrate ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.

Regulatory Classification

Presentation/Packing

Form

Lipiduce 160 FC tab 160 mg

Packing/Price

10 × 10's

Lipiduce 160

fenofibrate

Manufacturer:

Unison

Distributor:

JustRight Healthcare